Uzbekistan blames India-made cough syrup for deaths of 18 children

Indian maker of syrup linked to death of children in Uzbekistan halts production

India’s drug regulator said on Thursday that it had inspected Marion Biotech’s production facility and promised more action based on the probe report after

India probes cough syrups linked to Uzbekistan child deaths

NEW DELHI -- India has opened another investigation into cough syrup in response to Uzbekistan's claim that 18 children died after consuming an Indian

Uzbekistan cough syrup deaths: Firm pauses manufacture of syrup, probe launched

MedicineUnion Health Minister Mansukh Mandaviya said further action would be taken based on the inspection of the pharma company, Marion Biotech, after the Uzbekistan health ministry's allegation that the children died after consuming Doc-1 Max.PTITwitterThe manufacturing of Marion Biotech's Doc-1 Max has stopped "for now", the company's legal representative said on Thursday, December 29, as the Central Drugs Standard Control Organisation (CDSCO…

India Probes Uzbekistan Claim That 18 Kids Killed by Cough Syrup

India is investigating claims made by Uzbekistan’s government that 18 children died after ingesting a cough syrup brand made in the South Asian nation just two months after a similar tragedy was reported in Gambia.

Uzbekistan links 18 child deaths to cough syrup from India, prompting halt in production of the medicine

The Uzbekistan fatalities come after the deaths of 70 children in The Gambia and almost 200 people in Indonesia were linked to cough syrups.

India probes cough syrup blamed for Uzbek child deaths

Marion Biotech is the second local drugmaker to face a probe by regulators since October, when the World Health Organization linked another firm's medicines to a spate of child deaths in Africa.